UFP Technologies, Inc. (NASDAQ:UFPT) Stock Position Reduced by Laurus Investment Counsel Inc.

Laurus Investment Counsel Inc. lessened its stake in UFP Technologies, Inc. (NASDAQ:UFPT) by 15.3% during the 4th quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 5,260 shares of the industrial products company’s stock after selling 950 shares during the quarter. Laurus Investment Counsel Inc. owned 0.07% of UFP Technologies worth $1,286,000 at the end of the most recent reporting period.

A number of other institutional investors also recently modified their holdings of the stock. Swedbank AB grew its stake in shares of UFP Technologies by 33.3% in the 4th quarter. Swedbank AB now owns 80,000 shares of the industrial products company’s stock valued at $19,561,000 after buying an additional 20,000 shares in the last quarter. KBC Group NV grew its position in UFP Technologies by 37.9% in the fourth quarter. KBC Group NV now owns 375 shares of the industrial products company’s stock worth $92,000 after acquiring an additional 103 shares in the last quarter. Tributary Capital Management LLC acquired a new position in shares of UFP Technologies during the 4th quarter worth $122,000. Inspire Investing LLC raised its holdings in shares of UFP Technologies by 29.9% during the 4th quarter. Inspire Investing LLC now owns 1,681 shares of the industrial products company’s stock valued at $411,000 after purchasing an additional 387 shares in the last quarter. Finally, SG Americas Securities LLC lifted its stake in shares of UFP Technologies by 95.6% in the 4th quarter. SG Americas Securities LLC now owns 2,220 shares of the industrial products company’s stock valued at $543,000 after purchasing an additional 1,085 shares during the last quarter. Institutional investors and hedge funds own 87.28% of the company’s stock.

UFP Technologies Trading Down 0.5 %

Shares of UFPT stock opened at $274.66 on Friday. UFP Technologies, Inc. has a 12 month low of $167.51 and a 12 month high of $366.41. The company has a market cap of $2.11 billion, a PE ratio of 39.18 and a beta of 1.04. The company has a quick ratio of 1.43, a current ratio of 2.57 and a debt-to-equity ratio of 0.64. The business’s 50 day moving average is $268.13 and its two-hundred day moving average is $298.08.

Wall Street Analysts Forecast Growth

Separately, StockNews.com downgraded shares of UFP Technologies from a “hold” rating to a “sell” rating in a research report on Thursday, January 23rd.

Insider Activity at UFP Technologies

In other news, VP Jason Holt sold 146 shares of the stock in a transaction that occurred on Tuesday, November 12th. The stock was sold at an average price of $342.69, for a total value of $50,032.74. Following the completion of the sale, the vice president now directly owns 6,721 shares of the company’s stock, valued at approximately $2,303,219.49. This represents a 2.13 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Cynthia L. Feldmann sold 647 shares of the firm’s stock in a transaction on Friday, November 8th. The stock was sold at an average price of $352.30, for a total transaction of $227,938.10. Following the completion of the sale, the director now owns 4,049 shares in the company, valued at approximately $1,426,462.70. The trade was a 13.78 % decrease in their position. The disclosure for this sale can be found here. In the last three months, insiders have sold 13,326 shares of company stock worth $4,620,154. 6.17% of the stock is owned by insiders.

UFP Technologies Profile

UFP Technologies, Inc designs and manufactures solutions for medical devices, sterile packaging, and other highly engineered custom products. The company offers protective drapes for robotic surgery, single patient use surfaces, advanced wound care, infection prevention, disposables for surgical and endoscopic procedures, packaging for medical devices, orthopedic implants, biopharma drug manufacturing, and coils for catheters; and molded components for applications in acoustic insulation, interior trim, load floors, sunshades, SUV cargo cover handles, driveshaft damping, engine and manifold covers, quarter panels, and wheel liners.